[Retransplant].

Area of Science:

• Nephrology
• Immunology
• Transplantation Medicine

Context:

• Graft loss remains a significant challenge in kidney transplantation, with 20-30% of patients losing grafts within 3 years.
• Patients experiencing graft loss often return to maintenance dialysis, with 40-60% awaiting retransplantation.
• The presence of HLA antibodies complicates retransplantation for patients needing a second or third kidney transplant.

Purpose:

• To evaluate the outcomes and considerations for retransplantation in patients with previous kidney graft loss.
• To highlight retransplantation as a viable option for improving patient outcomes compared to continued dialysis.
• To discuss factors influencing retransplantation success, including patient demographics and immunological status.

Summary:

• Retransplantation is the optimal therapeutic strategy for patients with failed kidney grafts, offering outcomes comparable to first-time transplants.
• Diabetic patients and those aged 18-50 generally experience the best results after retransplantation.
• Specific considerations for retransplantation include avoiding repeat HLA antigen mismatches and ensuring negative cross-match results. Certain conditions like lymphoproliferative diseases do not preclude retransplantation.

Impact:

• Retransplantation significantly improves patient outcomes compared to remaining on dialysis waiting lists.
• Understanding the criteria for retransplantation can help optimize waiting list management and graft allocation.
• This research supports continued efforts to improve retransplantation strategies for end-stage renal disease patients.